Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy

Status unconfirmed · Not applicable

Conditions studied: Gastric Cancer

In brief

Screening esophagogastroduodenoscopy (EGD )provides three distinct opportunities to decrease gastric cancer (GC) morbidity and mortality. has potential to discover cancer in early stages before the onset of symptoms, leading to higher rates of survival. Second, premalignant lesions such as adenomatous polyps, intestinal metaplasia and dysplasia can be discovered and removed with local resection, akin to polypectomies during screening colonoscopies, preventing the development of cancer. Third, EGD discovery and treatment of active Helicobacter pylori (HP) infection of the stomach provides an opportunity for primary prevention of GC.

Key facts

Study ID

NCT05566899

Run by

Rutgers, The State University of New Jersey

People needed

50

Starts

2023-02-08

Expected to finish

2024-08-01

Last updated by the study team

2023-09-21

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Have provided signed informed consent for the trial
• Aged =40 and =80 years at the time of informed consent
• Not planned to undergo EGD and not had EGD in the last five years
• Planned to undergo colonoscopy
• Half of the recruited subjects will be from high-risk groups
• Willing and able to comply with all aspects of the protocol

You may not qualify if…

• Persons with total gastrectomy
• Persons with anatomic alteration that precludes EGD
• Medical conditions that substantially increase risks for EGD
• Had EGD in the last five years

Where it is running

• Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States (enrolling)
• RWJBarnabas Health — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.